Tissue Regenix Analyst Q&A: Very well positioned to reach breakeven and become cash generative (LON:TRX) 29 October 2020
Tatton Asset Management Analyst Q&A: AuM 4% above Zeus Capital expectations (LON:TAM) 27 October 2020
BlackRock Greater Europe Investment Trust quality driven and consistently outperforming peers (Analyst Interview)
Accrol Group Holdings LTC Acquisition immediately earnings enhancing with ongoing growth (Analyst Interview)
Allergy Therapeutics Excellent performance shown in FH1’17 Interim results – Zeus Capital 29 March 2017
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Ruffer Investment Company reports October gains as equities and UK bonds lift performance 12 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Zigup PLC (ZIG.L): Investor Outlook Reveals a 36.98% Potential Upside with Robust Dividend Yield 14 November 2025
Wizz Air Holdings (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a 26.16% Potential Upside 14 November 2025
Trustpilot Group PLC (TRST.L) Stock Analysis: Examining a Potential 78% Upside Opportunity 14 November 2025
Temple Bar Investment Trust Pl (TMPL.L) Investor Outlook: A Solid Dividend Play with Robust Revenue Growth 14 November 2025
Tissue Regenix Analyst Q&A: Very well positioned to reach breakeven and become cash generative (LON:TRX) 29 October 2020
Tatton Asset Management Analyst Q&A: AuM 4% above Zeus Capital expectations (LON:TAM) 27 October 2020
BlackRock Greater Europe Investment Trust quality driven and consistently outperforming peers (Analyst Interview)
Accrol Group Holdings LTC Acquisition immediately earnings enhancing with ongoing growth (Analyst Interview)
Allergy Therapeutics Excellent performance shown in FH1’17 Interim results – Zeus Capital 29 March 2017
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Ruffer Investment Company reports October gains as equities and UK bonds lift performance 12 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Zigup PLC (ZIG.L): Investor Outlook Reveals a 36.98% Potential Upside with Robust Dividend Yield 14 November 2025
Wizz Air Holdings (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a 26.16% Potential Upside 14 November 2025
Trustpilot Group PLC (TRST.L) Stock Analysis: Examining a Potential 78% Upside Opportunity 14 November 2025
Temple Bar Investment Trust Pl (TMPL.L) Investor Outlook: A Solid Dividend Play with Robust Revenue Growth 14 November 2025
Thermo Fisher Scientific Inc. Share Price Target ‘$659.04’, now 18.2% Upside Potential 28 October 2024
Jefferies Financial Group Inc. Share Price Target ‘$69.50’, now 7.6% Upside Potential 28 October 2024
Graphic Packaging Holding Company Share Price Target ‘$32.75’, now 9.0% Upside Potential 28 October 2024
BlackRock Greater Europe Investment Trust quality driven and consistently outperforming peers (Analyst Interview) 25 November 2020
Accrol Group Holdings LTC Acquisition immediately earnings enhancing with ongoing growth (Analyst Interview) 25 November 2020
Avacta Group make significant progress with its highly scalable lateral flow test (Interview) 23 November 2020
Non-Standard Finance profits and profitability could increase sharply (Analyst Interview) 23 November 2020
Impax Environmental Markets declares 2.9p second interim dividend for 2023, increase of 15% 2 February 2024
Foresight Group raises £180M in fundraising, expands Dublin office and achieves strong fund performance 1 February 2024
FDM Group delivered a resilient performance in 2023 despite challenging market conditions 31 January 2024
BTG appoints Shruthi Chindalur as Independent Non-Executive Director, strengthening Cloud Services expertise 31 January 2024
Tissue Regenix Analyst Q&A: Very well positioned to reach breakeven and become cash generative (LON:TRX) 29 October 2020
Tatton Asset Management Analyst Q&A: AuM 4% above Zeus Capital expectations (LON:TAM) 27 October 2020
Allergy Therapeutics Excellent performance shown in FH1’17 Interim results – Zeus Capital 29 March 2017
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Ruffer Investment Company reports October gains as equities and UK bonds lift performance 12 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Zigup PLC (ZIG.L): Investor Outlook Reveals a 36.98% Potential Upside with Robust Dividend Yield 14 November 2025
Wizz Air Holdings (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a 26.16% Potential Upside 14 November 2025
Trustpilot Group PLC (TRST.L) Stock Analysis: Examining a Potential 78% Upside Opportunity 14 November 2025
Temple Bar Investment Trust Pl (TMPL.L) Investor Outlook: A Solid Dividend Play with Robust Revenue Growth 14 November 2025
